DongKook Pharmaceutical Co (XKRX:086450) Other Long Term Assets : ₩131,471 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co Other Long Term Assets?

DongKook Pharmaceutical Co's other long-term assets for the quarter that ended in Dec. 2023 was ₩131,471 Mil.

DongKook Pharmaceutical Co's quarterly other long-term assets increased from Jun. 2023 (₩125,975 Mil) to Sep. 2023 (₩131,686 Mil) but then stayed the same from Sep. 2023 (₩131,686 Mil) to Dec. 2023 (₩131,471 Mil).

DongKook Pharmaceutical Co's annual other long-term assets increased from Dec. 2021 (₩87,993 Mil) to Dec. 2022 (₩108,780 Mil) and increased from Dec. 2022 (₩108,780 Mil) to Dec. 2023 (₩131,471 Mil).

DongKook Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for DongKook Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co Other Long Term Assets Chart

DongKook Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

43,043.47

62,135.78

87,993.16

108,779.98

131,470.70

DongKook Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															108,779.98	125,159.80	125,974.80	131,685.93	131,470.70

DongKook Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

DongKook Pharmaceutical Co (XKRX:086450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » Other Long Term Assets

Traded in Other Exchanges

N/A

Address

Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502

Website

http://www.dkpharm.co.kr

DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co (XKRX:086450) Headlines

No Headlines